Ovarian stimulation by clomiphene citrate and hMG in combination with cetrorelix acetate for ICSI cycles

Human Reproduction

Volumn 18, Issue 1, 2003, Pages 45-49

  Hwang, Jiann Loung ^a   Huang, Lee Wen ^a   Hsieh, Bih Chwen ^a   Tsai, Yieh Loong ^a   Huang, Shih Chia ^a   Chen, Chin Yu ^a   Hsieh, Mei Ling ^a   Chen, Pei Hsin ^a   Lin, Yu Hung ^a  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Cetrorelix acetate; Clomiphene citrate; GnRH antagonist; hMG

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; ESTRADIOL; FOLLITROPIN; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DOSE RESPONSE; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; ESTRADIOL BLOOD LEVEL; FEASIBILITY STUDY; FEMALE; FOLLITROPIN BLOOD LEVEL; HEALTH CARE COST; HORMONE INHIBITION; HORMONE RESPONSE; HUMAN; INJECTION; INTRACYTOPLASMIC SPERM INJECTION; LUTEINIZING HORMONE BLOOD LEVEL; LUTEINIZING HORMONE RELEASE; MALE; MALE INFERTILITY; OVARY FOLLICLE; OVULATION INDUCTION; PREGNANCY; PROGESTERONE BLOOD LEVEL; SINGLE DRUG DOSE;

EID: 0037253127     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deg021     Document Type: Article

References (21)

1. Albano, C., Felberbaum, R.E., Smitz, J., Riethmuller-Winzen, H., Engel, J., Diedrich, K. and Devroey, P. (2000) Ovarian stimulation with HMG: Results of a prospective randomized phase I European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. Hum. Reprod., 15, 526-531.
2. Al-Inany, H. and Aboulghar, M. (2002) GnRH antagonist in assisted reproduction: A Cochrane review. Hum. Reprod., 17, 874-885.
3. Biljan, M.M. and Tan, S.L. (1998). GnRH agonists in gonadotropin ovulation induction: Characteristics of long regimens. In Filicori, M. and Flamigni, C. (eds), Ovulation Induction: Update 98. The Parthenon Publishing Group, New York, London, pp. 75-82.
4. Craft, I., Gorgy, A., Hill, J., Hill, J., Menon, D. and Podsiadly, B. (1999) Will GnRH antagonists provide new hope for patients considered 'difficult responders' to GnRH agonist protocol? Hum. Reprod., 14, 2959-2962.
5. Diamond, M.P., Hill, G.A., Webster, B.W., Herbert, C.M., Rogers, B.J, Osteen, K.G., Maxson, W.S., Vaughn, W.K. and Wentz, A.C. (1986) Comparison of human menopausal gonadotropin, clomiphene citrate, and combined human menopausal gonadotropin-clomiphene citrate stimulation protocols for in vitro fertilization. Fertil. Steril., 46, 1108-1112.
6. Dickey, R.P., Olar, T.T., Taylor, S.N., Curole, D.N. and Rye, P.H. (1993) Sequential clomiphene citrate and human menopausal gonadotrophin for ovulation induction: Comparison to clomiphene citrate alone and human menopausal gonadotrophin alone. Hum. Reprod., 8, 56-59.
7. Diedrich, K., Diedrich, C., Santos, Zoll, E.C., Al-Hasani, S., Reissmann, T., Krebs, D. and Klingmuller, D. (1994) Supression of the endogenous LH-surge by the GnRH antagonist cetrorelix® during ovarian stimulation. Hum. Reprod., 9, 788-791.
8. Edwards, R.G., Lobo, R. and Bouchard, P. (1996) Time to revolutionize ovarian stimulation. Hum. Reprod., 11, 917-919.
9. Eibschitz, I., Belaish-Allart, J. and Fryman, R. (1986) In vitro fertilization management and results in stimulated cycles with spontaneous luteinizing hormone discharge. Fertil. Steril., 45, 231-234.
10. European and Middle East Orgalutran study group (2001) Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin undergoing ovarian stimulation. Hum. Reprod., 16, 644-651.
11. Felberbaum, R. and Diedrich, K. (1998) Ovarian stimulation in ART: Use of GnRH-antagonists. In Kempers, R.D., Cohen, J., Haney, A.E. and Younger, J.B. (eds), Fertility and Reproductive Medicine. Elsevier Science B.V., Amsterdam, pp 113-125.
12. Hwang, J.L., Lin, Y.H., Huang, S.C., Hsieh, M.L., Hsieh, B.C. and Tsai, Y.L. (2001) Pregnancy after intentional cryopreservation of percutaneous sperm aspiration specimens and intracytoplasmic sperm injection. J Reprod. Med., 46, 249-252.
13. Irvine, D.S. (1998) Epidemiology and etiology of male infertility. Hum. Reprod., 13 (Suppl. 1), 31-44.
14. Nikolettos, N., Al-Hasani, S., Felberbaum, R., Demirel, L.C., Kupker, W., Montzka, P. et al. (2001) Gonadotropin-releasing hormone antagonist protocol: A novel method of ovarian stimulation in poor responders. Eur. J. Obstet. Gynecol. Reprod. Biol., 97, 202-207.
15. Olivennes, F., Alvarez, S., Bouchard, P. et al. (1998) The use of GnRH antagonist (cetrorelix®) in a single dose protocol in IVF-embryo transfer: A dose finding study of 3 versus mg. Hum. Reprod., 13, 2411-2414.
16. Olivennes, F., Belaisch-Allart, J., Emperaire, J. Dechaud, H., Alvarex, S., Nicollet, B., Zorn, J.R., Bouchard, P. and Frydman, R. (2000) Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). Fertil. Steril., 73, 314-320.
17. Smitz, J., Ron-El, R. and Tarlatzis, B.C. (1992) The use of gonadotrophin releasing hormone agonists for in-vitro fertilization and other assisted procreation technique: Experience from three centres. Hum. Reprod., 7, 49-66.
18. Tavaniotou, A., Albano, C., Smitz, J. and Devroey, P. (2002) Effect of clomiphene citrate on follicular and luteal phase luteinizing hormone concentrations in in vitro fertilization cycles stimulated with gonadotropins and gonadotropin-releasing hormone antagonist. Fertil. Steril., 77, 733-737
19. Thonneau, P., Marchand, S., Tallec, A., Ferial, M.L., Ducot, B., Landsec, J., Tabaste, J.M. and Spira, A. (1991) Incidence and main causes of infertility in a resident population (1 850 000) of three French regions (1988-1989). Hum. Reprod., 6, 811-816.
20. Ubaldi, F., Albano, C., Peukerti, M., Riethmuller-Winsen, H., Camus, M., Smitz, J., Van Steirteghem, A. and Devroey, P. (1996) Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist cetrorelix in intracytoplasmic sperm injection cycles. Hum. Reprod., 11, 1405-1407.
21. Van Steirtegham, A.C., Joris, H., Liu, J., Staessen, C., Smitz, J., Wisanto, A. and Devroey, P. (1993) High fertilization and implantation rates after intracytoplasmic sperm injection. Hum. Reprod., 8, 1061-1066.